nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—NAT2—breast cancer	0.401	1	CbGaD
Ezogabine—UGT1A4—Tamoxifen—breast cancer	0.131	0.39	CbGbCtD
Ezogabine—CYP2A6—Letrozole—breast cancer	0.0866	0.257	CbGbCtD
Ezogabine—UGT1A9—Irinotecan—breast cancer	0.0407	0.121	CbGbCtD
Ezogabine—UGT1A1—Irinotecan—breast cancer	0.0333	0.0989	CbGbCtD
Ezogabine—CYP2A6—Tamoxifen—breast cancer	0.0258	0.0765	CbGbCtD
Ezogabine—CYP2A6—Fluorouracil—breast cancer	0.019	0.0564	CbGbCtD
Ezogabine—KCNQ5—female reproductive system—breast cancer	0.000341	0.112	CbGeAlD
Ezogabine—NAT2—endocrine gland—breast cancer	0.000339	0.111	CbGeAlD
Ezogabine—KCNQ2—pituitary gland—breast cancer	0.000275	0.0904	CbGeAlD
Ezogabine—KCNQ3—female reproductive system—breast cancer	0.000274	0.0899	CbGeAlD
Ezogabine—UGT1A3—endocrine gland—breast cancer	0.000257	0.0845	CbGeAlD
Ezogabine—KCNQ2—female reproductive system—breast cancer	0.000252	0.0827	CbGeAlD
Ezogabine—KCNQ2—female gonad—breast cancer	0.000229	0.0753	CbGeAlD
Ezogabine—UGT1A4—endocrine gland—breast cancer	0.000219	0.0718	CbGeAlD
Ezogabine—KCNQ2—endocrine gland—breast cancer	0.000213	0.07	CbGeAlD
Ezogabine—KCNQ5—lymph node—breast cancer	0.000199	0.0655	CbGeAlD
Ezogabine—UGT1A9—endocrine gland—breast cancer	0.000183	0.0602	CbGeAlD
Ezogabine—CYP2A6—adipose tissue—breast cancer	0.000136	0.0447	CbGeAlD
Ezogabine—UGT1A1—endocrine gland—breast cancer	0.000126	0.0413	CbGeAlD
Ezogabine—Mental disorder—Docetaxel—breast cancer	8.18e-05	0.000592	CcSEcCtD
Ezogabine—Somnolence—Fluorouracil—breast cancer	8.17e-05	0.000592	CcSEcCtD
Ezogabine—Anxiety—Paclitaxel—breast cancer	8.13e-05	0.000589	CcSEcCtD
Ezogabine—Malnutrition—Docetaxel—breast cancer	8.12e-05	0.000589	CcSEcCtD
Ezogabine—Dyspepsia—Fluorouracil—breast cancer	8.09e-05	0.000586	CcSEcCtD
Ezogabine—Nausea—Tamoxifen—breast cancer	8.08e-05	0.000585	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Gemcitabine—breast cancer	8.07e-05	0.000584	CcSEcCtD
Ezogabine—Discomfort—Paclitaxel—breast cancer	8.06e-05	0.000584	CcSEcCtD
Ezogabine—Fatigue—Gemcitabine—breast cancer	8.06e-05	0.000584	CcSEcCtD
Ezogabine—Constipation—Gemcitabine—breast cancer	7.99e-05	0.000579	CcSEcCtD
Ezogabine—Alopecia—Capecitabine—breast cancer	7.98e-05	0.000578	CcSEcCtD
Ezogabine—Dry mouth—Paclitaxel—breast cancer	7.98e-05	0.000578	CcSEcCtD
Ezogabine—Asthenia—Thiotepa—breast cancer	7.97e-05	0.000577	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Fluorouracil—breast cancer	7.93e-05	0.000575	CcSEcCtD
Ezogabine—Mental disorder—Capecitabine—breast cancer	7.92e-05	0.000573	CcSEcCtD
Ezogabine—Nausea—Melphalan—breast cancer	7.91e-05	0.000573	CcSEcCtD
Ezogabine—Feeling abnormal—Mitoxantrone—breast cancer	7.9e-05	0.000573	CcSEcCtD
Ezogabine—Feeling abnormal—Irinotecan—breast cancer	7.9e-05	0.000573	CcSEcCtD
Ezogabine—Confusional state—Paclitaxel—breast cancer	7.89e-05	0.000571	CcSEcCtD
Ezogabine—Malnutrition—Capecitabine—breast cancer	7.87e-05	0.00057	CcSEcCtD
Ezogabine—Influenza—Epirubicin—breast cancer	7.86e-05	0.00057	CcSEcCtD
Ezogabine—Dysphagia—Epirubicin—breast cancer	7.86e-05	0.00057	CcSEcCtD
Ezogabine—Neutropenia—Methotrexate—breast cancer	7.86e-05	0.000569	CcSEcCtD
Ezogabine—Dysuria—Methotrexate—breast cancer	7.86e-05	0.000569	CcSEcCtD
Ezogabine—Muscle spasms—Docetaxel—breast cancer	7.81e-05	0.000566	CcSEcCtD
Ezogabine—Liver function test abnormal—Doxorubicin—breast cancer	7.77e-05	0.000563	CcSEcCtD
Ezogabine—Infection—Paclitaxel—breast cancer	7.77e-05	0.000563	CcSEcCtD
Ezogabine—Nausea—Goserelin—breast cancer	7.71e-05	0.000559	CcSEcCtD
Ezogabine—Feeling abnormal—Gemcitabine—breast cancer	7.7e-05	0.000558	CcSEcCtD
Ezogabine—Shock—Paclitaxel—breast cancer	7.7e-05	0.000558	CcSEcCtD
Ezogabine—Dizziness—Vinorelbine—breast cancer	7.69e-05	0.000557	CcSEcCtD
Ezogabine—Nervous system disorder—Paclitaxel—breast cancer	7.67e-05	0.000556	CcSEcCtD
Ezogabine—Thrombocytopenia—Paclitaxel—breast cancer	7.66e-05	0.000555	CcSEcCtD
Ezogabine—Feeling abnormal—Fluorouracil—breast cancer	7.57e-05	0.000548	CcSEcCtD
Ezogabine—Muscle spasms—Capecitabine—breast cancer	7.56e-05	0.000548	CcSEcCtD
Ezogabine—Hyperhidrosis—Paclitaxel—breast cancer	7.56e-05	0.000548	CcSEcCtD
Ezogabine—Infestation NOS—Methotrexate—breast cancer	7.49e-05	0.000543	CcSEcCtD
Ezogabine—Infestation—Methotrexate—breast cancer	7.49e-05	0.000543	CcSEcCtD
Ezogabine—Vision blurred—Capecitabine—breast cancer	7.41e-05	0.000537	CcSEcCtD
Ezogabine—Tremor—Capecitabine—breast cancer	7.37e-05	0.000534	CcSEcCtD
Ezogabine—Dysuria—Epirubicin—breast cancer	7.35e-05	0.000533	CcSEcCtD
Ezogabine—Neutropenia—Epirubicin—breast cancer	7.35e-05	0.000533	CcSEcCtD
Ezogabine—Dizziness—Thiotepa—breast cancer	7.34e-05	0.000532	CcSEcCtD
Ezogabine—Rash—Vinorelbine—breast cancer	7.33e-05	0.000531	CcSEcCtD
Ezogabine—Dermatitis—Vinorelbine—breast cancer	7.33e-05	0.000531	CcSEcCtD
Ezogabine—Ill-defined disorder—Capecitabine—breast cancer	7.3e-05	0.000529	CcSEcCtD
Ezogabine—Syncope—Docetaxel—breast cancer	7.29e-05	0.000528	CcSEcCtD
Ezogabine—Dysphagia—Doxorubicin—breast cancer	7.28e-05	0.000527	CcSEcCtD
Ezogabine—Influenza—Doxorubicin—breast cancer	7.28e-05	0.000527	CcSEcCtD
Ezogabine—Leukopenia—Docetaxel—breast cancer	7.27e-05	0.000527	CcSEcCtD
Ezogabine—Weight increased—Epirubicin—breast cancer	7.16e-05	0.000518	CcSEcCtD
Ezogabine—Haematuria—Methotrexate—breast cancer	7.14e-05	0.000518	CcSEcCtD
Ezogabine—Loss of consciousness—Docetaxel—breast cancer	7.14e-05	0.000517	CcSEcCtD
Ezogabine—Malaise—Capecitabine—breast cancer	7.09e-05	0.000514	CcSEcCtD
Ezogabine—Hepatobiliary disease—Methotrexate—breast cancer	7.09e-05	0.000513	CcSEcCtD
Ezogabine—Vertigo—Capecitabine—breast cancer	7.07e-05	0.000512	CcSEcCtD
Ezogabine—Syncope—Capecitabine—breast cancer	7.05e-05	0.000511	CcSEcCtD
Ezogabine—Leukopenia—Capecitabine—breast cancer	7.04e-05	0.00051	CcSEcCtD
Ezogabine—Paraesthesia—Paclitaxel—breast cancer	7.02e-05	0.000509	CcSEcCtD
Ezogabine—Infestation NOS—Epirubicin—breast cancer	7.01e-05	0.000508	CcSEcCtD
Ezogabine—Infestation—Epirubicin—breast cancer	7.01e-05	0.000508	CcSEcCtD
Ezogabine—Rash—Thiotepa—breast cancer	7e-05	0.000507	CcSEcCtD
Ezogabine—Dermatitis—Thiotepa—breast cancer	7e-05	0.000507	CcSEcCtD
Ezogabine—Dyspnoea—Paclitaxel—breast cancer	6.97e-05	0.000505	CcSEcCtD
Ezogabine—Somnolence—Paclitaxel—breast cancer	6.95e-05	0.000504	CcSEcCtD
Ezogabine—Loss of consciousness—Capecitabine—breast cancer	6.91e-05	0.000501	CcSEcCtD
Ezogabine—Nausea—Vinorelbine—breast cancer	6.91e-05	0.0005	CcSEcCtD
Ezogabine—Dyspepsia—Paclitaxel—breast cancer	6.89e-05	0.000499	CcSEcCtD
Ezogabine—Asthenia—Mitoxantrone—breast cancer	6.88e-05	0.000499	CcSEcCtD
Ezogabine—Asthenia—Irinotecan—breast cancer	6.88e-05	0.000499	CcSEcCtD
Ezogabine—Dysuria—Doxorubicin—breast cancer	6.8e-05	0.000493	CcSEcCtD
Ezogabine—Neutropenia—Doxorubicin—breast cancer	6.8e-05	0.000493	CcSEcCtD
Ezogabine—Dry mouth—Docetaxel—breast cancer	6.76e-05	0.00049	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Paclitaxel—breast cancer	6.75e-05	0.000489	CcSEcCtD
Ezogabine—Fatigue—Paclitaxel—breast cancer	6.74e-05	0.000489	CcSEcCtD
Ezogabine—Asthenia—Gemcitabine—breast cancer	6.7e-05	0.000486	CcSEcCtD
Ezogabine—Constipation—Paclitaxel—breast cancer	6.69e-05	0.000485	CcSEcCtD
Ezogabine—Haematuria—Epirubicin—breast cancer	6.69e-05	0.000484	CcSEcCtD
Ezogabine—Confusional state—Docetaxel—breast cancer	6.69e-05	0.000484	CcSEcCtD
Ezogabine—Anxiety—Capecitabine—breast cancer	6.67e-05	0.000483	CcSEcCtD
Ezogabine—Urinary tract disorder—Methotrexate—breast cancer	6.64e-05	0.000481	CcSEcCtD
Ezogabine—Hepatobiliary disease—Epirubicin—breast cancer	6.63e-05	0.00048	CcSEcCtD
Ezogabine—Weight increased—Doxorubicin—breast cancer	6.62e-05	0.00048	CcSEcCtD
Ezogabine—Discomfort—Capecitabine—breast cancer	6.62e-05	0.000479	CcSEcCtD
Ezogabine—Nausea—Thiotepa—breast cancer	6.6e-05	0.000478	CcSEcCtD
Ezogabine—Urethral disorder—Methotrexate—breast cancer	6.59e-05	0.000478	CcSEcCtD
Ezogabine—Infection—Docetaxel—breast cancer	6.59e-05	0.000477	CcSEcCtD
Ezogabine—Dry mouth—Capecitabine—breast cancer	6.55e-05	0.000474	CcSEcCtD
Ezogabine—Shock—Docetaxel—breast cancer	6.52e-05	0.000473	CcSEcCtD
Ezogabine—Nervous system disorder—Docetaxel—breast cancer	6.5e-05	0.000471	CcSEcCtD
Ezogabine—Thrombocytopenia—Docetaxel—breast cancer	6.49e-05	0.00047	CcSEcCtD
Ezogabine—Infestation NOS—Doxorubicin—breast cancer	6.49e-05	0.00047	CcSEcCtD
Ezogabine—Infestation—Doxorubicin—breast cancer	6.49e-05	0.00047	CcSEcCtD
Ezogabine—Visual impairment—Methotrexate—breast cancer	6.48e-05	0.00047	CcSEcCtD
Ezogabine—Confusional state—Capecitabine—breast cancer	6.47e-05	0.000469	CcSEcCtD
Ezogabine—Feeling abnormal—Paclitaxel—breast cancer	6.45e-05	0.000467	CcSEcCtD
Ezogabine—Infection—Capecitabine—breast cancer	6.38e-05	0.000462	CcSEcCtD
Ezogabine—Dizziness—Irinotecan—breast cancer	6.34e-05	0.000459	CcSEcCtD
Ezogabine—Shock—Capecitabine—breast cancer	6.32e-05	0.000458	CcSEcCtD
Ezogabine—Nervous system disorder—Capecitabine—breast cancer	6.3e-05	0.000456	CcSEcCtD
Ezogabine—Eye disorder—Methotrexate—breast cancer	6.29e-05	0.000455	CcSEcCtD
Ezogabine—Thrombocytopenia—Capecitabine—breast cancer	6.29e-05	0.000455	CcSEcCtD
Ezogabine—Urinary tract disorder—Epirubicin—breast cancer	6.22e-05	0.00045	CcSEcCtD
Ezogabine—Hyperhidrosis—Capecitabine—breast cancer	6.21e-05	0.00045	CcSEcCtD
Ezogabine—Oedema peripheral—Epirubicin—breast cancer	6.2e-05	0.000449	CcSEcCtD
Ezogabine—Haematuria—Doxorubicin—breast cancer	6.19e-05	0.000448	CcSEcCtD
Ezogabine—Urethral disorder—Epirubicin—breast cancer	6.17e-05	0.000447	CcSEcCtD
Ezogabine—Hepatobiliary disease—Doxorubicin—breast cancer	6.14e-05	0.000445	CcSEcCtD
Ezogabine—Dizziness—Fluorouracil—breast cancer	6.07e-05	0.00044	CcSEcCtD
Ezogabine—Visual impairment—Epirubicin—breast cancer	6.07e-05	0.000439	CcSEcCtD
Ezogabine—Rash—Irinotecan—breast cancer	6.05e-05	0.000438	CcSEcCtD
Ezogabine—Rash—Mitoxantrone—breast cancer	6.05e-05	0.000438	CcSEcCtD
Ezogabine—Dermatitis—Irinotecan—breast cancer	6.04e-05	0.000438	CcSEcCtD
Ezogabine—Dermatitis—Mitoxantrone—breast cancer	6.04e-05	0.000438	CcSEcCtD
Ezogabine—Paraesthesia—Docetaxel—breast cancer	5.95e-05	0.000431	CcSEcCtD
Ezogabine—Alopecia—Methotrexate—breast cancer	5.94e-05	0.000431	CcSEcCtD
Ezogabine—Dyspnoea—Docetaxel—breast cancer	5.91e-05	0.000428	CcSEcCtD
Ezogabine—Somnolence—Docetaxel—breast cancer	5.89e-05	0.000427	CcSEcCtD
Ezogabine—Mental disorder—Methotrexate—breast cancer	5.89e-05	0.000427	CcSEcCtD
Ezogabine—Rash—Gemcitabine—breast cancer	5.89e-05	0.000427	CcSEcCtD
Ezogabine—Dermatitis—Gemcitabine—breast cancer	5.89e-05	0.000426	CcSEcCtD
Ezogabine—Eye disorder—Epirubicin—breast cancer	5.88e-05	0.000426	CcSEcCtD
Ezogabine—Malnutrition—Methotrexate—breast cancer	5.86e-05	0.000424	CcSEcCtD
Ezogabine—Dyspepsia—Docetaxel—breast cancer	5.84e-05	0.000423	CcSEcCtD
Ezogabine—Rash—Fluorouracil—breast cancer	5.79e-05	0.00042	CcSEcCtD
Ezogabine—Dermatitis—Fluorouracil—breast cancer	5.79e-05	0.000419	CcSEcCtD
Ezogabine—Paraesthesia—Capecitabine—breast cancer	5.76e-05	0.000418	CcSEcCtD
Ezogabine—Urinary tract disorder—Doxorubicin—breast cancer	5.75e-05	0.000417	CcSEcCtD
Ezogabine—Oedema peripheral—Doxorubicin—breast cancer	5.74e-05	0.000416	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Docetaxel—breast cancer	5.72e-05	0.000415	CcSEcCtD
Ezogabine—Dyspnoea—Capecitabine—breast cancer	5.72e-05	0.000415	CcSEcCtD
Ezogabine—Fatigue—Docetaxel—breast cancer	5.72e-05	0.000414	CcSEcCtD
Ezogabine—Urethral disorder—Doxorubicin—breast cancer	5.71e-05	0.000414	CcSEcCtD
Ezogabine—Nausea—Mitoxantrone—breast cancer	5.7e-05	0.000413	CcSEcCtD
Ezogabine—Nausea—Irinotecan—breast cancer	5.7e-05	0.000413	CcSEcCtD
Ezogabine—Constipation—Docetaxel—breast cancer	5.67e-05	0.000411	CcSEcCtD
Ezogabine—Dyspepsia—Capecitabine—breast cancer	5.65e-05	0.000409	CcSEcCtD
Ezogabine—Visual impairment—Doxorubicin—breast cancer	5.61e-05	0.000407	CcSEcCtD
Ezogabine—Asthenia—Paclitaxel—breast cancer	5.61e-05	0.000407	CcSEcCtD
Ezogabine—Alopecia—Epirubicin—breast cancer	5.56e-05	0.000403	CcSEcCtD
Ezogabine—Nausea—Gemcitabine—breast cancer	5.55e-05	0.000402	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Capecitabine—breast cancer	5.54e-05	0.000401	CcSEcCtD
Ezogabine—Fatigue—Capecitabine—breast cancer	5.53e-05	0.000401	CcSEcCtD
Ezogabine—Vision blurred—Methotrexate—breast cancer	5.52e-05	0.0004	CcSEcCtD
Ezogabine—Mental disorder—Epirubicin—breast cancer	5.51e-05	0.0004	CcSEcCtD
Ezogabine—Constipation—Capecitabine—breast cancer	5.49e-05	0.000398	CcSEcCtD
Ezogabine—Malnutrition—Epirubicin—breast cancer	5.48e-05	0.000397	CcSEcCtD
Ezogabine—Feeling abnormal—Docetaxel—breast cancer	5.46e-05	0.000396	CcSEcCtD
Ezogabine—Nausea—Fluorouracil—breast cancer	5.46e-05	0.000395	CcSEcCtD
Ezogabine—Eye disorder—Doxorubicin—breast cancer	5.44e-05	0.000394	CcSEcCtD
Ezogabine—Ill-defined disorder—Methotrexate—breast cancer	5.43e-05	0.000394	CcSEcCtD
Ezogabine—Feeling abnormal—Capecitabine—breast cancer	5.29e-05	0.000383	CcSEcCtD
Ezogabine—Malaise—Methotrexate—breast cancer	5.28e-05	0.000383	CcSEcCtD
Ezogabine—Muscle spasms—Epirubicin—breast cancer	5.27e-05	0.000382	CcSEcCtD
Ezogabine—Vertigo—Methotrexate—breast cancer	5.26e-05	0.000381	CcSEcCtD
Ezogabine—Leukopenia—Methotrexate—breast cancer	5.24e-05	0.00038	CcSEcCtD
Ezogabine—Dizziness—Paclitaxel—breast cancer	5.17e-05	0.000375	CcSEcCtD
Ezogabine—Vision blurred—Epirubicin—breast cancer	5.16e-05	0.000374	CcSEcCtD
Ezogabine—Alopecia—Doxorubicin—breast cancer	5.15e-05	0.000373	CcSEcCtD
Ezogabine—Mental disorder—Doxorubicin—breast cancer	5.1e-05	0.00037	CcSEcCtD
Ezogabine—Ill-defined disorder—Epirubicin—breast cancer	5.08e-05	0.000368	CcSEcCtD
Ezogabine—Malnutrition—Doxorubicin—breast cancer	5.07e-05	0.000367	CcSEcCtD
Ezogabine—Malaise—Epirubicin—breast cancer	4.94e-05	0.000358	CcSEcCtD
Ezogabine—Rash—Paclitaxel—breast cancer	4.93e-05	0.000357	CcSEcCtD
Ezogabine—Dermatitis—Paclitaxel—breast cancer	4.93e-05	0.000357	CcSEcCtD
Ezogabine—Discomfort—Methotrexate—breast cancer	4.93e-05	0.000357	CcSEcCtD
Ezogabine—Vertigo—Epirubicin—breast cancer	4.92e-05	0.000357	CcSEcCtD
Ezogabine—Syncope—Epirubicin—breast cancer	4.91e-05	0.000356	CcSEcCtD
Ezogabine—Leukopenia—Epirubicin—breast cancer	4.91e-05	0.000355	CcSEcCtD
Ezogabine—Muscle spasms—Doxorubicin—breast cancer	4.87e-05	0.000353	CcSEcCtD
Ezogabine—Confusional state—Methotrexate—breast cancer	4.82e-05	0.000349	CcSEcCtD
Ezogabine—Loss of consciousness—Epirubicin—breast cancer	4.82e-05	0.000349	CcSEcCtD
Ezogabine—Vision blurred—Doxorubicin—breast cancer	4.78e-05	0.000346	CcSEcCtD
Ezogabine—Asthenia—Docetaxel—breast cancer	4.76e-05	0.000345	CcSEcCtD
Ezogabine—Infection—Methotrexate—breast cancer	4.75e-05	0.000344	CcSEcCtD
Ezogabine—Ill-defined disorder—Doxorubicin—breast cancer	4.7e-05	0.000341	CcSEcCtD
Ezogabine—Nervous system disorder—Methotrexate—breast cancer	4.69e-05	0.00034	CcSEcCtD
Ezogabine—Thrombocytopenia—Methotrexate—breast cancer	4.68e-05	0.000339	CcSEcCtD
Ezogabine—Anxiety—Epirubicin—breast cancer	4.65e-05	0.000337	CcSEcCtD
Ezogabine—Nausea—Paclitaxel—breast cancer	4.65e-05	0.000337	CcSEcCtD
Ezogabine—Hyperhidrosis—Methotrexate—breast cancer	4.62e-05	0.000335	CcSEcCtD
Ezogabine—Discomfort—Epirubicin—breast cancer	4.61e-05	0.000334	CcSEcCtD
Ezogabine—Asthenia—Capecitabine—breast cancer	4.61e-05	0.000334	CcSEcCtD
Ezogabine—Malaise—Doxorubicin—breast cancer	4.57e-05	0.000331	CcSEcCtD
Ezogabine—Dry mouth—Epirubicin—breast cancer	4.56e-05	0.000331	CcSEcCtD
Ezogabine—Vertigo—Doxorubicin—breast cancer	4.56e-05	0.00033	CcSEcCtD
Ezogabine—Syncope—Doxorubicin—breast cancer	4.55e-05	0.000329	CcSEcCtD
Ezogabine—Leukopenia—Doxorubicin—breast cancer	4.54e-05	0.000329	CcSEcCtD
Ezogabine—Confusional state—Epirubicin—breast cancer	4.51e-05	0.000327	CcSEcCtD
Ezogabine—Loss of consciousness—Doxorubicin—breast cancer	4.46e-05	0.000323	CcSEcCtD
Ezogabine—Infection—Epirubicin—breast cancer	4.44e-05	0.000322	CcSEcCtD
Ezogabine—Shock—Epirubicin—breast cancer	4.4e-05	0.000319	CcSEcCtD
Ezogabine—Nervous system disorder—Epirubicin—breast cancer	4.39e-05	0.000318	CcSEcCtD
Ezogabine—Dizziness—Docetaxel—breast cancer	4.38e-05	0.000318	CcSEcCtD
Ezogabine—Thrombocytopenia—Epirubicin—breast cancer	4.38e-05	0.000317	CcSEcCtD
Ezogabine—Hyperhidrosis—Epirubicin—breast cancer	4.32e-05	0.000313	CcSEcCtD
Ezogabine—Anxiety—Doxorubicin—breast cancer	4.3e-05	0.000312	CcSEcCtD
Ezogabine—Paraesthesia—Methotrexate—breast cancer	4.29e-05	0.000311	CcSEcCtD
Ezogabine—Discomfort—Doxorubicin—breast cancer	4.26e-05	0.000309	CcSEcCtD
Ezogabine—Dyspnoea—Methotrexate—breast cancer	4.26e-05	0.000309	CcSEcCtD
Ezogabine—Somnolence—Methotrexate—breast cancer	4.25e-05	0.000308	CcSEcCtD
Ezogabine—Dizziness—Capecitabine—breast cancer	4.25e-05	0.000308	CcSEcCtD
Ezogabine—Dry mouth—Doxorubicin—breast cancer	4.22e-05	0.000306	CcSEcCtD
Ezogabine—Dyspepsia—Methotrexate—breast cancer	4.21e-05	0.000305	CcSEcCtD
Ezogabine—Rash—Docetaxel—breast cancer	4.18e-05	0.000303	CcSEcCtD
Ezogabine—Dermatitis—Docetaxel—breast cancer	4.18e-05	0.000303	CcSEcCtD
Ezogabine—Confusional state—Doxorubicin—breast cancer	4.17e-05	0.000302	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Methotrexate—breast cancer	4.13e-05	0.000299	CcSEcCtD
Ezogabine—Fatigue—Methotrexate—breast cancer	4.12e-05	0.000298	CcSEcCtD
Ezogabine—Infection—Doxorubicin—breast cancer	4.11e-05	0.000298	CcSEcCtD
Ezogabine—Shock—Doxorubicin—breast cancer	4.07e-05	0.000295	CcSEcCtD
Ezogabine—Nervous system disorder—Doxorubicin—breast cancer	4.06e-05	0.000294	CcSEcCtD
Ezogabine—Thrombocytopenia—Doxorubicin—breast cancer	4.05e-05	0.000294	CcSEcCtD
Ezogabine—Rash—Capecitabine—breast cancer	4.05e-05	0.000293	CcSEcCtD
Ezogabine—Dermatitis—Capecitabine—breast cancer	4.04e-05	0.000293	CcSEcCtD
Ezogabine—Paraesthesia—Epirubicin—breast cancer	4.02e-05	0.000291	CcSEcCtD
Ezogabine—Hyperhidrosis—Doxorubicin—breast cancer	4e-05	0.00029	CcSEcCtD
Ezogabine—Dyspnoea—Epirubicin—breast cancer	3.99e-05	0.000289	CcSEcCtD
Ezogabine—Somnolence—Epirubicin—breast cancer	3.98e-05	0.000288	CcSEcCtD
Ezogabine—Nausea—Docetaxel—breast cancer	3.94e-05	0.000285	CcSEcCtD
Ezogabine—Feeling abnormal—Methotrexate—breast cancer	3.94e-05	0.000285	CcSEcCtD
Ezogabine—Dyspepsia—Epirubicin—breast cancer	3.94e-05	0.000285	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Epirubicin—breast cancer	3.86e-05	0.00028	CcSEcCtD
Ezogabine—Fatigue—Epirubicin—breast cancer	3.86e-05	0.000279	CcSEcCtD
Ezogabine—Constipation—Epirubicin—breast cancer	3.82e-05	0.000277	CcSEcCtD
Ezogabine—Nausea—Capecitabine—breast cancer	3.81e-05	0.000276	CcSEcCtD
Ezogabine—Paraesthesia—Doxorubicin—breast cancer	3.72e-05	0.000269	CcSEcCtD
Ezogabine—Dyspnoea—Doxorubicin—breast cancer	3.69e-05	0.000267	CcSEcCtD
Ezogabine—Feeling abnormal—Epirubicin—breast cancer	3.69e-05	0.000267	CcSEcCtD
Ezogabine—Somnolence—Doxorubicin—breast cancer	3.68e-05	0.000266	CcSEcCtD
Ezogabine—Dyspepsia—Doxorubicin—breast cancer	3.64e-05	0.000264	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.57e-05	0.000259	CcSEcCtD
Ezogabine—Fatigue—Doxorubicin—breast cancer	3.57e-05	0.000258	CcSEcCtD
Ezogabine—Constipation—Doxorubicin—breast cancer	3.54e-05	0.000256	CcSEcCtD
Ezogabine—Asthenia—Methotrexate—breast cancer	3.43e-05	0.000248	CcSEcCtD
Ezogabine—Feeling abnormal—Doxorubicin—breast cancer	3.41e-05	0.000247	CcSEcCtD
Ezogabine—Asthenia—Epirubicin—breast cancer	3.21e-05	0.000232	CcSEcCtD
Ezogabine—Dizziness—Methotrexate—breast cancer	3.16e-05	0.000229	CcSEcCtD
Ezogabine—Rash—Methotrexate—breast cancer	3.01e-05	0.000218	CcSEcCtD
Ezogabine—Dermatitis—Methotrexate—breast cancer	3.01e-05	0.000218	CcSEcCtD
Ezogabine—Asthenia—Doxorubicin—breast cancer	2.97e-05	0.000215	CcSEcCtD
Ezogabine—Dizziness—Epirubicin—breast cancer	2.96e-05	0.000214	CcSEcCtD
Ezogabine—Nausea—Methotrexate—breast cancer	2.84e-05	0.000206	CcSEcCtD
Ezogabine—Rash—Epirubicin—breast cancer	2.82e-05	0.000204	CcSEcCtD
Ezogabine—Dermatitis—Epirubicin—breast cancer	2.82e-05	0.000204	CcSEcCtD
Ezogabine—Dizziness—Doxorubicin—breast cancer	2.74e-05	0.000198	CcSEcCtD
Ezogabine—Nausea—Epirubicin—breast cancer	2.66e-05	0.000192	CcSEcCtD
Ezogabine—Rash—Doxorubicin—breast cancer	2.61e-05	0.000189	CcSEcCtD
Ezogabine—Dermatitis—Doxorubicin—breast cancer	2.61e-05	0.000189	CcSEcCtD
Ezogabine—Nausea—Doxorubicin—breast cancer	2.46e-05	0.000178	CcSEcCtD
Ezogabine—UGT1A1—Metabolism—NAT2—breast cancer	9.89e-06	8.19e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—FASN—breast cancer	9.71e-06	8.04e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—BCHE—breast cancer	9.67e-06	8.01e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FHL2—breast cancer	9.65e-06	7.99e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADSL—breast cancer	9.65e-06	7.99e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PHGDH—breast cancer	9.65e-06	7.99e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—UMPS—breast cancer	9.65e-06	7.99e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NME1—breast cancer	9.65e-06	7.99e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC5A5—breast cancer	9.55e-06	7.91e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BRIP1—breast cancer	9.46e-06	7.83e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HPSE—breast cancer	9.46e-06	7.83e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LDHB—breast cancer	9.46e-06	7.83e-05	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT1—breast cancer	9.4e-06	7.79e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT1—breast cancer	9.4e-06	7.79e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—COMT—breast cancer	9.3e-06	7.7e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTP1—breast cancer	9.26e-06	7.66e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC2A1—breast cancer	9.23e-06	7.64e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NQO1—breast cancer	9.23e-06	7.64e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CD—breast cancer	9.17e-06	7.59e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HMOX1—breast cancer	9.13e-06	7.56e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ITPR1—breast cancer	9.11e-06	7.54e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALB—breast cancer	9.05e-06	7.49e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP3A4—breast cancer	9e-06	7.45e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCC1—breast cancer	8.97e-06	7.43e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMMR—breast cancer	8.97e-06	7.43e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTA3—breast cancer	8.97e-06	7.43e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.94e-06	7.4e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP1B1—breast cancer	8.85e-06	7.32e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCB1—breast cancer	8.76e-06	7.25e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARGC1B—breast cancer	8.69e-06	7.19e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HSP90AA1—breast cancer	8.67e-06	7.18e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MED12—breast cancer	8.67e-06	7.18e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MED12—breast cancer	8.67e-06	7.18e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—DPYD—breast cancer	8.67e-06	7.18e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—DPYD—breast cancer	8.67e-06	7.18e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NOS3—breast cancer	8.65e-06	7.17e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TYMS—breast cancer	8.61e-06	7.13e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALDOA—breast cancer	8.54e-06	7.07e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALDOA—breast cancer	8.54e-06	7.07e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PLA2G4A—breast cancer	8.51e-06	7.04e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NCOR1—breast cancer	8.51e-06	7.04e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTM1—breast cancer	8.51e-06	7.04e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NCOA1—breast cancer	8.44e-06	6.99e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—STK11—breast cancer	8.32e-06	6.89e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP19A1—breast cancer	8.32e-06	6.89e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NCOA3—breast cancer	8.29e-06	6.86e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NCOA3—breast cancer	8.29e-06	6.86e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A2—breast cancer	8.23e-06	6.82e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A2—breast cancer	8.23e-06	6.82e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTA4—breast cancer	8.2e-06	6.79e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA9—breast cancer	8.2e-06	6.79e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GPX1—breast cancer	8.15e-06	6.74e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.15e-06	6.74e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCG2—breast cancer	8.06e-06	6.68e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP1A1—breast cancer	8.06e-06	6.68e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCG2—breast cancer	8.06e-06	6.68e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CPT1A—breast cancer	8.06e-06	6.68e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CPT1A—breast cancer	8.06e-06	6.68e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTR—breast cancer	8.06e-06	6.68e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTR—breast cancer	8.06e-06	6.68e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ERCC2—breast cancer	8e-06	6.62e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTA2—breast cancer	7.99e-06	6.62e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPX2—breast cancer	7.99e-06	6.62e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CB—breast cancer	7.99e-06	6.61e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—breast cancer	7.92e-06	6.55e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HPGDS—breast cancer	7.91e-06	6.55e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HPGDS—breast cancer	7.91e-06	6.55e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPX4—breast cancer	7.9e-06	6.54e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SULT1A1—breast cancer	7.9e-06	6.54e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HBA1—breast cancer	7.86e-06	6.51e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HBA1—breast cancer	7.86e-06	6.51e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—COMT—breast cancer	7.73e-06	6.4e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTA1—breast cancer	7.71e-06	6.39e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—IDH1—breast cancer	7.71e-06	6.39e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTP1—breast cancer	7.7e-06	6.37e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ACHE—breast cancer	7.67e-06	6.35e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTT1—breast cancer	7.67e-06	6.35e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ACHE—breast cancer	7.67e-06	6.35e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTT1—breast cancer	7.67e-06	6.35e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NAT2—breast cancer	7.63e-06	6.31e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMOX1—breast cancer	7.59e-06	6.28e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ITPR1—breast cancer	7.57e-06	6.27e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—breast cancer	7.52e-06	6.22e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCB1—breast cancer	7.28e-06	6.03e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP17A1—breast cancer	7.26e-06	6.01e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP17A1—breast cancer	7.26e-06	6.01e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ENO1—breast cancer	7.19e-06	5.95e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS1—breast cancer	7.19e-06	5.95e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS1—breast cancer	7.19e-06	5.95e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ENO1—breast cancer	7.19e-06	5.95e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.16e-06	5.93e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TYMS—breast cancer	7.15e-06	5.92e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PLA2G4A—breast cancer	7.07e-06	5.85e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTM1—breast cancer	7.07e-06	5.85e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NCOR1—breast cancer	7.07e-06	5.85e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.07e-06	5.85e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2D6—breast cancer	7.05e-06	5.84e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2D6—breast cancer	7.05e-06	5.84e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CAV1—breast cancer	6.93e-06	5.74e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NCOA2—breast cancer	6.92e-06	5.73e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NCOA2—breast cancer	6.92e-06	5.73e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTEN—breast cancer	6.9e-06	5.72e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GPX1—breast cancer	6.77e-06	5.61e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—FASN—breast cancer	6.71e-06	5.56e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—FASN—breast cancer	6.71e-06	5.56e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP1A1—breast cancer	6.7e-06	5.55e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MED12—breast cancer	6.69e-06	5.54e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—DPYD—breast cancer	6.69e-06	5.54e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BCHE—breast cancer	6.68e-06	5.53e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BCHE—breast cancer	6.68e-06	5.53e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ERCC2—breast cancer	6.65e-06	5.5e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC5A5—breast cancer	6.6e-06	5.46e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC5A5—breast cancer	6.6e-06	5.46e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALDOA—breast cancer	6.58e-06	5.45e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NCOA3—breast cancer	6.39e-06	5.29e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A1—breast cancer	6.37e-06	5.28e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A1—breast cancer	6.37e-06	5.28e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NQO1—breast cancer	6.37e-06	5.28e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NQO1—breast cancer	6.37e-06	5.28e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A2—breast cancer	6.35e-06	5.25e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CG—breast cancer	6.32e-06	5.23e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—breast cancer	6.25e-06	5.17e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.24e-06	5.17e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CPT1A—breast cancer	6.22e-06	5.15e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTR—breast cancer	6.22e-06	5.15e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP3A4—breast cancer	6.22e-06	5.15e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCG2—breast cancer	6.22e-06	5.15e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP3A4—breast cancer	6.22e-06	5.15e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.19e-06	5.12e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP1B1—breast cancer	6.11e-06	5.06e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP1B1—breast cancer	6.11e-06	5.06e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HPGDS—breast cancer	6.1e-06	5.05e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HBA1—breast cancer	6.06e-06	5.02e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HSP90AA1—breast cancer	5.99e-06	4.96e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HSP90AA1—breast cancer	5.99e-06	4.96e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTT1—breast cancer	5.91e-06	4.9e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ACHE—breast cancer	5.91e-06	4.9e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NCOA1—breast cancer	5.83e-06	4.83e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NCOA1—breast cancer	5.83e-06	4.83e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CAV1—breast cancer	5.76e-06	4.77e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP19A1—breast cancer	5.75e-06	4.76e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP19A1—breast cancer	5.75e-06	4.76e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—STK11—breast cancer	5.75e-06	4.76e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—STK11—breast cancer	5.75e-06	4.76e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP17A1—breast cancer	5.6e-06	4.63e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CD—breast cancer	5.55e-06	4.6e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS1—breast cancer	5.54e-06	4.59e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ENO1—breast cancer	5.54e-06	4.59e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALB—breast cancer	5.48e-06	4.54e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2D6—breast cancer	5.43e-06	4.5e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.39e-06	4.47e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—COMT—breast cancer	5.34e-06	4.42e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—COMT—breast cancer	5.34e-06	4.42e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NCOA2—breast cancer	5.33e-06	4.42e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTP1—breast cancer	5.32e-06	4.4e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTP1—breast cancer	5.32e-06	4.4e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CG—breast cancer	5.25e-06	4.35e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMOX1—breast cancer	5.24e-06	4.34e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NOS3—breast cancer	5.24e-06	4.34e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMOX1—breast cancer	5.24e-06	4.34e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ITPR1—breast cancer	5.23e-06	4.33e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ITPR1—breast cancer	5.23e-06	4.33e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FASN—breast cancer	5.17e-06	4.28e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BCHE—breast cancer	5.15e-06	4.26e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC5A5—breast cancer	5.09e-06	4.21e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCB1—breast cancer	5.03e-06	4.17e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCB1—breast cancer	5.03e-06	4.17e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TYMS—breast cancer	4.94e-06	4.09e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TYMS—breast cancer	4.94e-06	4.09e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A1—breast cancer	4.91e-06	4.07e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NQO1—breast cancer	4.91e-06	4.07e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTM1—breast cancer	4.89e-06	4.05e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLA2G4A—breast cancer	4.89e-06	4.05e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NCOR1—breast cancer	4.89e-06	4.05e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NCOR1—breast cancer	4.89e-06	4.05e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTM1—breast cancer	4.89e-06	4.05e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLA2G4A—breast cancer	4.89e-06	4.05e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CA—breast cancer	4.87e-06	4.03e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CB—breast cancer	4.84e-06	4.01e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—breast cancer	4.8e-06	3.97e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP3A4—breast cancer	4.79e-06	3.97e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP1B1—breast cancer	4.71e-06	3.9e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GPX1—breast cancer	4.68e-06	3.87e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GPX1—breast cancer	4.68e-06	3.87e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP1A1—breast cancer	4.63e-06	3.83e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP1A1—breast cancer	4.63e-06	3.83e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSP90AA1—breast cancer	4.62e-06	3.83e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CD—breast cancer	4.62e-06	3.82e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ERCC2—breast cancer	4.59e-06	3.8e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ERCC2—breast cancer	4.59e-06	3.8e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALB—breast cancer	4.56e-06	3.77e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NCOA1—breast cancer	4.49e-06	3.72e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—STK11—breast cancer	4.43e-06	3.67e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP19A1—breast cancer	4.43e-06	3.67e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NOS3—breast cancer	4.36e-06	3.61e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—breast cancer	4.32e-06	3.58e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—breast cancer	4.32e-06	3.58e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTEN—breast cancer	4.18e-06	3.46e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—COMT—breast cancer	4.12e-06	3.41e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTP1—breast cancer	4.1e-06	3.39e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMOX1—breast cancer	4.04e-06	3.35e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ITPR1—breast cancer	4.03e-06	3.34e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CB—breast cancer	4.02e-06	3.33e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—breast cancer	3.99e-06	3.3e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CAV1—breast cancer	3.98e-06	3.3e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CAV1—breast cancer	3.98e-06	3.3e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKT1—breast cancer	3.98e-06	3.29e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCB1—breast cancer	3.88e-06	3.21e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TYMS—breast cancer	3.81e-06	3.15e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.81e-06	3.15e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLA2G4A—breast cancer	3.77e-06	3.12e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTM1—breast cancer	3.77e-06	3.12e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NCOR1—breast cancer	3.77e-06	3.12e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CG—breast cancer	3.63e-06	3e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CG—breast cancer	3.63e-06	3e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPX1—breast cancer	3.61e-06	2.99e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP1A1—breast cancer	3.57e-06	2.96e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ERCC2—breast cancer	3.54e-06	2.93e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTEN—breast cancer	3.48e-06	2.88e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—breast cancer	3.33e-06	2.76e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CD—breast cancer	3.19e-06	2.64e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CD—breast cancer	3.19e-06	2.64e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALB—breast cancer	3.15e-06	2.61e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALB—breast cancer	3.15e-06	2.61e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CAV1—breast cancer	3.07e-06	2.54e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NOS3—breast cancer	3.01e-06	2.49e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NOS3—breast cancer	3.01e-06	2.49e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CA—breast cancer	2.95e-06	2.44e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CG—breast cancer	2.8e-06	2.32e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CB—breast cancer	2.78e-06	2.3e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CB—breast cancer	2.78e-06	2.3e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—breast cancer	2.75e-06	2.28e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—breast cancer	2.75e-06	2.28e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CD—breast cancer	2.46e-06	2.04e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CA—breast cancer	2.45e-06	2.03e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALB—breast cancer	2.43e-06	2.01e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKT1—breast cancer	2.41e-06	2e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTEN—breast cancer	2.4e-06	1.99e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTEN—breast cancer	2.4e-06	1.99e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NOS3—breast cancer	2.32e-06	1.92e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CB—breast cancer	2.14e-06	1.77e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—breast cancer	2.12e-06	1.76e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKT1—breast cancer	2e-06	1.66e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTEN—breast cancer	1.85e-06	1.53e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CA—breast cancer	1.69e-06	1.4e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CA—breast cancer	1.69e-06	1.4e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKT1—breast cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKT1—breast cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CA—breast cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKT1—breast cancer	1.07e-06	8.84e-06	CbGpPWpGaD
